Conversely, immune activity-related signatures, including PRF1, GNLY, GZMA, GZMB, and interferon regulatory factor 1, play crucial roles in tumor cell recognition and tumoricidal, with connections to extended survival, and identifying responders to anti-PD-1 antibody treatment [40, 41]. This evidence concerns the gene PRF1 and neoplasm.